Cite
APA Citation
Vasan, N., Razavi, P., Johnson, J. L., Shao, H., Reznik, E., Smith, M. L., Sebra, R., Cantley, L. C., Scaltriti, M., & Baselga, J. (n.d.). 1ODouble PIK3CA mutations in cis enhance PI3Kα oncogene activation and sensitivity to PI3Kα inhibitors in breast cancer. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100092358787.0x000034